Ono Warns on Profit After Govt Halves Price of Opdivo


Ono Pharmaceutical Co cut its annual profit outlook by a quarter on Wednesday, hit by the Japanese government’s decision to halve the price of cancer drug Opdivo that it co-developed with Bristol Myers Squibb Co.
Reuters Health Information